Literature DB >> 730493

o,p'--DDD and adrenal carcinoma.

P McKiernan, D A Doyle, G J Duffy, R P Towers, F A Duff, D K O'Donovan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 730493     DOI： 10.1007/bf02939448

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  8 in total

1.  Metastatic adrenal cortical carcinoma. Documented cure with combined chemotherapy.

Authors:  J A Ostuni; M S Roginsky
Journal:  Arch Intern Med       Date:  1975-09

2.  Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases.

Authors:  D A MACFARLANE
Journal:  Ann R Coll Surg Engl       Date:  1958-09       Impact factor: 1.891

3.  Biological studies on an adrenocorticolytic agent and the isolation of the active components.

Authors:  C CUETO; J H BROWN; A P RICHARDSON
Journal:  Endocrinology       Date:  1958-03       Impact factor: 4.736

4.  o,p'DDD therapy in invasive adrenocortical carcinoma.

Authors:  D Becker; O P Schumacher
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

5.  Mitotane use in inoperable adrenal cortical carcinoma.

Authors:  J A Lubitz; L Freeman; R Okun
Journal:  JAMA       Date:  1973-03-05       Impact factor: 56.272

6.  Treatment of adrenocortical carcinoma with o,p'-DDD.

Authors:  D L Hoffman; V R Mattox
Journal:  Med Clin North Am       Date:  1972-07       Impact factor: 5.456

7.  Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients.

Authors:  A M Hutter; D E Kayhoe
Journal:  Am J Med       Date:  1966-10       Impact factor: 4.965

8.  Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(parachlorophenyl)-1,1-dichloroethane (DDD or TDE).

Authors:  A A NELSON; G WOODARD
Journal:  Arch Pathol (Chic)       Date:  1949-11
  8 in total
  1 in total

1.  O,p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy.

Authors:  H von Slooten; A P van Seters; D Smeenk; A J Moolenaar
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.